Report
Martin Marandon-Carlhian ...
  • Stephane Houri

BE Semiconductor Industries : L’un des meilleurs véhicules d’investissement européen pour jouer l’accélération de l’IA

>Opinion Surperformance confirmée, OC relevé à 180 € (vs 125 €) - Suite à un T4 23 solide sur l’ensemble des indicateurs, aux commentaires de BESI sur la reprise cyclique en 2024/26 et la poursuite de l’adoption de l’hybrid bonding, nous relevons nos prévisions de BPA de respectivement 4%, 9% et 20% sur 2024/25/26e. Nous maintenons nos prévisions pour l’hybrid bonding inchangées sur 2024 (120 M€) mais nous les relevons sur 2025 (260 M€ vs 240 M€) et 2026 (500 M€ vs 43...
Underlying
BE Semiconductor Industries N.V.

BE Semiconductor Industries N.V. (Besi) is a holding company. The Company is engaged in the development, manufacturing, marketing, sales and service of semiconductor assembly equipment for the global semiconductor and electronics industries. It operates through three segments: Die Attach, Packaging and Plating. It develops assembly processes and equipment for leadframe, substrate and wafer level packaging applications in a range of end user markets, including electronics, computer, automotive, industrial and solar energy. The Company offers products, such as Die attach equipment, which include single chip, multi-chip, multi module, flip chip, thermo-compression bonding (TCB) and enhanced wafer level ball grid array (eWLB) die bonding systems, and die sorting systems; Packaging equipment, which include wafer level molding and singulation systems, and Plating equipment, which include metal plating systems and related process chemicals.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Martin Marandon-Carlhian

Stephane Houri

ResearchPool Subscriptions

Get the most out of your insights

Get in touch